Krystal Biotech's total assets for Q4 2024 were $1.06B, an increase of 7.48% from the previous quarter. KRYS total liabilities were $109.46M for the fiscal quarter, a 13.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.